TradingKey

关于 IDEXX实验室公司

IDEXX Laboratories, Inc. 开发、生产和分销产品，并主要为伴侣动物兽医、牲畜和家禽、乳制品和水检测行业提供服务。该公司还提供人类医疗即时诊断和实验室诊断。其部门包括伴侣动物组 (CAG)、水质产品 (水) 以及牲畜、家禽和乳制品 (LPD)。CAG 部门为伴侣动物兽医行业提供基于诊断和信息管理的产品和服务，包括临床诊断解决方案、外部参考实验室服务以及兽医软件和服务。其水部门提供测试解决方案，用于准确检测和量化水中的各种微生物参数。其 LPD 部门提供诊断测试、服务和相关仪器，用于管理牲畜和家禽的健康状况，以提高牛奶的质量和安全性。

公司简介

公司代码IDXX

公司名称IDEXX Laboratories Inc

上市日期Jun 21, 1991

CEOMr. Andrew Emerson

员工数量11000

证券类型Ordinary Share

年结日Jun 21

公司地址One Idexx Drive

城市WESTBROOK

上市交易所NASDAQ Global Select Consolidated

国家United States of America

邮编04092-2041

电话12075560300

网址https://www.idexx.com/

公司代码IDXX

上市日期Jun 21, 1991

CEOMr. Andrew Emerson

公司高管

名称

名称/职务

职务

持股

持股变动

Mr. Michael Erickson, Ph.D.

Executive Vice President and General Manager, Point of Care Diagnostics and Telemedicine

12.58K

+18.05%

Dr. Sophie V. Vandebroek, Ph.D.

Independent Director

8.69K

+3.11%

Mr. Lawrence D. (Larry) Kingsley

Independent Chairman of the Board

8.23K

+4.39%

Mr. Michael J. Lane

Executive Vice President and General Manager, Global Reference Laboratories, Diagnostic Solutions and Information Technology

7.70K

--

Ms. Sharon E. Underberg

Executive Vice President, General Counsel, Corporate Secretary

6.12K

+3.08%

Mr. Andrew Emerson

Executive Vice President, Chief Executive Officer, Treasurer

3.84K

+60.39%

Mr. Daniel M. (Dan) Junius

Independent Director

3.00K

+9.56%

Mr. Michael Schreck

Executive Vice President and General Manager, Veterinary Software and Services, Corporate Accounts and Customer Experience

1.92K

+112.86%

Mr. Bruce L. Claflin

Independent Director

1.72K

--

Dr. Stuart M. Essig, Ph.D.

Independent Director

1.09K

+31.76%

名称

名称/职务

职务

持股

持股变动

Mr. Michael Erickson, Ph.D.

Executive Vice President and General Manager, Point of Care Diagnostics and Telemedicine

12.58K

+18.05%

Dr. Sophie V. Vandebroek, Ph.D.

Independent Director

8.69K

+3.11%

Mr. Lawrence D. (Larry) Kingsley

Independent Chairman of the Board

8.23K

+4.39%

Mr. Michael J. Lane

Executive Vice President and General Manager, Global Reference Laboratories, Diagnostic Solutions and Information Technology

7.70K

--

Ms. Sharon E. Underberg

Executive Vice President, General Counsel, Corporate Secretary

6.12K

+3.08%

Mr. Andrew Emerson

Executive Vice President, Chief Executive Officer, Treasurer

3.84K

+60.39%

收入明细

单位: USD更新时间: 7月6日周日

FY2025Q1

FY2024

FY2024Q4

FY2024Q3

FY2024Q2

FY2024Q1

FY2023

FY2023Q4

FY2023Q3

FY2023Q2

FY2023Q1

FY2022

FY2022Q4

FY2022Q3

FY2022Q2

FY2022Q1

FY2021

FY2020

FY2019

FY2018

业务USD

名称

营收

占比

CAG Diagnostics recurring revenue

806.27M

80.75%

IDEXX VetLab consumables

344.78M

34.53%

Reference laboratory diagnostic and consulting services

344.41M

34.49%

Rapid assay products

84.03M

8.42%

Veterinary software, services and diagnostic imaging systems

81.58M

8.17%

其他

-662.63M

-66.37%

地区USD

名称

营收

占比

United States

654.86M

65.59%

Europe & Middle East & Africa (EMEA) (Region)

204.55M

20.49%

Asia Pacific

81.73M

8.19%

Canada

37.30M

3.74%

Latin America

19.99M

2.00%

业务

地区

业务USD

名称

营收

占比

CAG Diagnostics recurring revenue

806.27M

80.75%

IDEXX VetLab consumables

344.78M

34.53%

Reference laboratory diagnostic and consulting services

344.41M

34.49%

Rapid assay products

84.03M

8.42%

Veterinary software, services and diagnostic imaging systems

81.58M

8.17%

其他

-662.63M

-66.37%

股东统计

更新时间: 8月19日周二

持股股东

股东类型

持股股东

占比

The Vanguard Group, Inc.

12.30%

BlackRock Institutional Trust Company, N.A.

6.63%

State Street Global Advisors (US)

4.44%

Fundsmith LLP

3.30%

Geode Capital Management, L.L.C.

3.08%

其他

70.25%

持股股东

占比

The Vanguard Group, Inc.

12.30%

BlackRock Institutional Trust Company, N.A.

6.63%

State Street Global Advisors (US)

4.44%

Fundsmith LLP

3.30%

Geode Capital Management, L.L.C.

3.08%

其他

70.25%

股东类型

持股股东

占比

Investment Advisor

54.31%

Investment Advisor/Hedge Fund

32.80%

Research Firm

3.95%

Pension Fund

2.29%

Bank and Trust

2.06%

Hedge Fund

0.93%

Individual Investor

0.69%

Sovereign Wealth Fund

0.61%

Family Office

0.54%

其他

1.83%

机构持股

更新时间: 7月1日周二

报告期

机构数

持股数

持股占比

持股变动

2025Q2

2277

79.81M

99.73%

-1.01M

2025Q1

2279

79.02M

98.21%

-512.23K

2024Q4

2242

76.14M

93.59%

-5.30M

2024Q3

2152

77.90M

94.66%

-4.67M

2024Q2

2140

80.09M

96.98%

-924.14K

2024Q1

2154

77.56M

93.40%

-2.57M

2023Q4

2187

77.94M

93.84%

-2.83M

2023Q3

2153

79.23M

95.34%

-677.16K

2023Q2

2157

77.53M

93.40%

-1.56M

2023Q1

2158

77.14M

92.96%

-2.07M

股东持股明细

名称

持股数

占比

持股变动

变动比例

公告日期

The Vanguard Group, Inc.

9.82M

12.21%

+146.37K

+1.51%

Mar 31, 2025

BlackRock Institutional Trust Company, N.A.

5.44M

6.76%

+113.70K

+2.14%

Mar 31, 2025

State Street Global Advisors (US)

3.65M

4.54%

+12.32K

+0.34%

Mar 31, 2025

Fundsmith LLP

2.65M

3.29%

-14.52K

-0.55%

Mar 31, 2025

Geode Capital Management, L.L.C.

2.41M

3%

+112.62K

+4.90%

Mar 31, 2025

Baron Capital Management, Inc.

2.06M

2.56%

+54.26K

+2.71%

Mar 31, 2025

Invesco Capital Management (QQQ Trust)

1.66M

2.07%

-25.31K

-1.50%

Jun 30, 2025

Principal Global Investors (Equity)

1.13M

1.4%

+414.80K

+58.32%

Mar 31, 2025

William Blair & Company, L.L.C. (Research)

1.09M

1.36%

-14.24K

-1.29%

Mar 31, 2025

持股ETF

更新时间: 9月6日周六

机构名称

占比

ProShares Pet Care ETF

10.39%

First Trust Water ETF

5.65%

iShares U.S. Medical Devices ETF

5.62%

Nuveen ESG Mid-Cap Growth ETF

3.56%

Simplify Next Intangible Core Index ETF

3.22%

Hennessy Sustainable ETF

3.19%

Adaptive Core ETF

2.75%

Janus Henderson Mid Cap Growth Alpha ETF

2.63%

Invesco Raymond James SB-1 Equity ETF

2.52%

First Trust S&P 500 Economic Moat Index ETF

2.42%

ProShares Pet Care ETF

占比10.39%

First Trust Water ETF

占比5.65%

iShares U.S. Medical Devices ETF

占比5.62%

Nuveen ESG Mid-Cap Growth ETF

占比3.56%

Simplify Next Intangible Core Index ETF

占比3.22%

Hennessy Sustainable ETF

占比3.19%

Adaptive Core ETF

占比2.75%

Janus Henderson Mid Cap Growth Alpha ETF

占比2.63%

Invesco Raymond James SB-1 Equity ETF

占比2.52%

First Trust S&P 500 Economic Moat Index ETF

占比2.42%

分红派息

近5年累计派现 0.00 美元

公告日期

分红计划

股权登记日

现金发放日

除权除息日

暂无数据

拆合股

公告日期

类型

比率

暂无数据

公告日期

类型

比率

暂无数据

IDEXX实验室

643.990USD

IDEXX实验室

643.990

概览

公司

财务

分析